Elba Laboratories

Executive Summary

Elba Laboratories is a full-service contract development and manufacturing organization (CDMO) based in San Diego, founded in 2018. The company serves the cosmetic, personal care, and topical pharmaceutical industries, offering end-to-end services from formulation and product development to compounding, filling, and analytical testing. Its cGMP facility supports both client projects and its own branded product line, EpiGyn®, which focuses on feminine skincare. As a CDMO, Elba Laboratories benefits from the growing trend of outsourcing in personal care and pharma, driven by the need for specialized expertise and cost efficiency. The company's ability to handle complex formulations and its focus on topical and cosmetic applications positions it well in a niche market. With no disclosed funding rounds, the company appears to be self-sustaining or privately funded, likely relying on operational revenue. The CDMO market is competitive, but Elba's specialization in feminine skincare and its EpiGyn brand could provide a competitive edge. Future growth may come from expanding client relationships, increasing capacity, or launching new products under EpiGyn.

Upcoming Catalysts (preview)

• Q3 2026Signing of a Major New Client Contract60% success
• Q4 2026Expansion of cGMP Manufacturing Capacity70% success
• Q2 2026Launch of a New EpiGyn Product Line50% success